{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:37:25Z","timestamp":1773931045412,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"am","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.revmed.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T17:11:07Z","timestamp":1645809067000},"page":"225-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Troubles min\u00e9raux et osseux dans la maladie r\u00e9nale chronique\u00a0: physiopathologie, cons\u00e9quences et prise en charge"],"prefix":"10.1016","volume":"43","author":[{"given":"F.","family":"Lavainne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-2064","authenticated-orcid":false,"given":"L.","family":"Figueres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.revmed.2022.01.009_bib0005","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3748\/wjg.v26.i24.3344","article-title":"Intestinal Ca 2+ absorption revisited: a molecular and clinical approach","volume":"26","author":"Areco","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem-67-5-944","article-title":"Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans","volume":"67","author":"Brent","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.revmed.2022.01.009_bib0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.revmed.2022.01.009_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, MECHANISM OF ACTION, AND CLINICAL APPLICAtions","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0025","doi-asserted-by":"crossref","first-page":"C1339","DOI":"10.1152\/ajpcell.00260.2009","article-title":"PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI","volume":"297","author":"Blaine","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"10.1016\/j.revmed.2022.01.009_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23\u00a0demonstrates an essential physiological role of FGF23\u00a0in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0035","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.revmed.2022.01.009_bib0040","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017\u00a0Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone\u00a0Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.revmed.2022.01.009_bib0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molmet.2018.02.007","article-title":"Phosphate-dependent FGF23\u00a0secretion is modulated by PiT2\/Slc20a2","volume":"11","author":"Bon","year":"2018","journal-title":"Mol Metab"},{"issue":"12","key":"10.1016\/j.revmed.2022.01.009_bib0055","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23\u00a0is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.revmed.2022.01.009_bib0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.revmed.2022.01.009_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.mnh.0000203187.49890.cc","article-title":"Post-renal transplantation hypophosphatemia: a review and novel insights","volume":"15","author":"Ghanekar","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0070","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.revmed.2022.01.009_bib0075","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0085","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","article-title":"Risk factors for hip fracture among patients with end-stage renal disease","volume":"58","author":"Stehman-Breen","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"25","author":"Maravic","year":"2014","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00198-014-2632-6","article-title":"Greater risk of hip fracture in hemodialysis than in peritoneal dialysis","volume":"25","author":"Chen","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2022.01.009_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2014.04.017","article-title":"Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study","volume":"64","author":"Lin","year":"2014","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.revmed.2022.01.009_bib0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1744-9987.12772","article-title":"Secondary hyperparathyroidism: pathogenesis and latest treatment","volume":"23","author":"Mizobuchi","year":"2019","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.revmed.2022.01.009_bib0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0115","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1016\/j.revmed.2022.01.009_bib0120","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0125","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2018111150","article-title":"A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD","volume":"30","author":"Sakaguchi","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","article-title":"Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats","volume":"92","author":"Diaz-Tocados","year":"2017","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.revmed.2022.01.009_bib0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneph.2011.110","article-title":"Noninvasive imaging for assessment of calcification in chronic kidney disease","volume":"7","author":"Karohl","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.revmed.2022.01.009_bib0150","first-page":"gfab053","article-title":"Cardiovascular calcifications in kidney transplant recipients","author":"Podest\u00e0","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0155","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.revmed.2022.01.009_bib0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9900","key":"10.1016\/j.revmed.2022.01.009_bib0165","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with ckd: a network meta-analysis of randomized trials","volume":"68","author":"Palmer","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"10.1016\/j.revmed.2022.01.009_bib0175","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2018.17749","article-title":"Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism receiving maintenance hemodialysis: The J-DAVID Randomized Clinical Trial","volume":"320","author":"Investigators","year":"2018","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.revmed.2022.01.009_bib0180","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.revmed.2022.01.009_bib0185","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00268-017-4000-0","article-title":"The effect of parathyroidectomy on risk of hip fracture in secondary hyperparathyroidism","volume":"41","author":"Isaksson","year":"2017","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0190","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.revmed.2022.01.009_bib0195","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00268-017-4000-0","article-title":"The effect of parathyroidectomy on risk of hip fracture in secondary hyperparathyroidism","volume":"41","author":"Isaksson","year":"2017","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0205","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.revmed.2022.01.009_bib0210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/jbmr.3961","article-title":"Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study","volume":"35","author":"Alarkawi","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2008.193","article-title":"Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women","volume":"74","author":"Boonen","year":"2008","journal-title":"Kidney Int"},{"issue":"18","key":"10.1016\/j.revmed.2022.01.009_bib0225","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.revmed.2022.01.009_bib0230","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.2008.344","article-title":"Once-yearly intravenous zoledronate does not impair renal function in postmenopausal women","volume":"74","author":"Lafage-Proust","year":"2008","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.revmed.2022.01.009_bib0240","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treatment in postmenopausal women with CKD","volume":"19","author":"Ishani","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0245","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.revmed.2022.01.009_bib0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease","volume":"106","author":"Broadwell","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"issue":"23","key":"10.1016\/j.revmed.2022.01.009_bib0260","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000000808","article-title":"Fracture incidence in adult kidney transplant recipients","volume":"100","author":"Naylor","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.revmed.2022.01.009_bib0270","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States","volume":"14","author":"Nair","year":"2014","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jbm4.10067","article-title":"Fracture risk in dialysis and kidney transplanted patients: a systematic review","volume":"3","author":"Sidib\u00e9","year":"2019","journal-title":"JBMR Plus"},{"issue":"5","key":"10.1016\/j.revmed.2022.01.009_bib0280","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00198-018-4383-2","article-title":"Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort","volume":"29","author":"Segaud","year":"2018","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.revmed.2022.01.009_bib0285","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.revmed.2022.01.009_bib0290","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/00007890-200012270-00011","article-title":"Posttransplant bone disease: evidence for a high bone resorption state","volume":"70","author":"Cayco","year":"2000","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0295","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and\u00a0incident fractures in de novo kidney transplant\u00a0recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.revmed.2022.01.009_bib0300","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.revmed.2022.01.009_bib0305","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","article-title":"Risk of fractures after renal transplantation in the United States","volume":"87","author":"Nikkel","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2022.01.009_bib0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bone.2019.07.006","article-title":"Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society","volume":"127","author":"Anastasilakis","year":"2019","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.revmed.2022.01.009_bib0315","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1097\/TP.0000000000001547","article-title":"Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab","volume":"101","author":"Bonani","year":"2017","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0320","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.revmed.2022.01.009_bib0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11657-019-0587-0","article-title":"Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis","volume":"14","author":"Thongprayoon","year":"2019","journal-title":"Arch Osteoporos"},{"issue":"6","key":"10.1016\/j.revmed.2022.01.009_bib0330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/imj.13744","article-title":"Acute hypocalcaemia following denosumab in heart and lung transplant patients with osteoporosis","volume":"48","author":"Shrosbree","year":"2018","journal-title":"Intern Med J"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:01Z","timestamp":1759337101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0248866322000303"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.01.009","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troubles min\u00e9raux et osseux dans la maladie r\u00e9nale chronique\u00a0: physiopathologie, cons\u00e9quences et prise en charge","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}